Robecosam AG Buys 259,625 Shares of Agilent Technologies Inc (NYSE:A)

Robecosam AG increased its stake in shares of Agilent Technologies Inc (NYSE:A) by 25.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,299,733 shares of the medical research company’s stock after buying an additional 259,625 shares during the quarter. Agilent Technologies comprises approximately 4.0% of Robecosam AG’s investment portfolio, making the stock its 3rd biggest position. Robecosam AG owned about 0.41% of Agilent Technologies worth $95,127,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. NEXT Financial Group Inc lifted its stake in Agilent Technologies by 22.0% during the second quarter. NEXT Financial Group Inc now owns 925 shares of the medical research company’s stock worth $69,000 after purchasing an additional 167 shares during the last quarter. Greenwood Capital Associates LLC lifted its stake in Agilent Technologies by 4.1% during the first quarter. Greenwood Capital Associates LLC now owns 4,670 shares of the medical research company’s stock worth $375,000 after purchasing an additional 185 shares during the last quarter. Fulton Bank N.A. lifted its stake in Agilent Technologies by 3.8% during the second quarter. Fulton Bank N.A. now owns 5,235 shares of the medical research company’s stock worth $391,000 after purchasing an additional 194 shares during the last quarter. Destination Wealth Management lifted its stake in Agilent Technologies by 100.0% during the first quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock worth $32,000 after purchasing an additional 200 shares during the last quarter. Finally, Flagship Harbor Advisors LLC lifted its stake in Agilent Technologies by 139.0% during the second quarter. Flagship Harbor Advisors LLC now owns 349 shares of the medical research company’s stock worth $26,000 after purchasing an additional 203 shares during the last quarter.

Several research firms have weighed in on A. Deutsche Bank cut their target price on Agilent Technologies from $90.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, May 15th. ValuEngine cut Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday, July 12th. Piper Jaffray Companies began coverage on Agilent Technologies in a research note on Tuesday, June 11th. They set an “overweight” rating and a $83.00 target price for the company. Zacks Investment Research cut Agilent Technologies from a “hold” rating to a “sell” rating and set a $71.00 target price for the company. in a research note on Tuesday, July 16th. Finally, Bank of America cut Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 target price for the company. in a research note on Tuesday, July 16th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the stock. Agilent Technologies currently has a consensus rating of “Buy” and a consensus target price of $83.92.

Shares of A traded up $1.32 during trading hours on Tuesday, reaching $67.95. The stock had a trading volume of 148,887 shares, compared to its average volume of 2,762,785. Agilent Technologies Inc has a 12 month low of $61.01 and a 12 month high of $82.27. The company has a market cap of $21.69 billion, a PE ratio of 24.35, a PEG ratio of 1.91 and a beta of 1.41. The company has a debt-to-equity ratio of 0.35, a current ratio of 3.41 and a quick ratio of 2.82. The stock has a 50-day moving average price of $71.09.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing the Zacks’ consensus estimate of $0.72 by ($0.01). Agilent Technologies had a net margin of 22.25% and a return on equity of 19.71%. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter in the previous year, the company posted $0.65 earnings per share. The firm’s revenue was up 2.7% on a year-over-year basis. On average, research analysts predict that Agilent Technologies Inc will post 3.05 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd were paid a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend was Monday, July 1st. Agilent Technologies’s payout ratio is 23.66%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Read More: Elliott Wave Theory

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.